# Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy

> **NCT00571116** · PHASE1 · TERMINATED · sponsor: **University of California, Irvine** · enrollment: 9 (actual)

## Conditions studied

- Metastatic Melanoma

## Interventions

- **DRUG:** Disulfiram
- **DRUG:** Arsenic trioxide

## Key facts

- **NCT ID:** NCT00571116
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Halted because of slow accrual and lack of study funding
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00571116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00571116, "Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00571116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*